HIQA’s CEA of Breast Screening: Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not-Reference-Cited by-同舟云学术

HIQA’s CEA of Breast Screening: Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not

Published:2015-12 Issue:8 Volume:18 Page:941-945
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

O’Mahony James F.,Normand Charles

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference35 articles.

1. Pharmacoeconomic evaluation in Ireland;Tilson;Pharmacoeconomics,2010

2. Oireachtas Éireann. Health Act 2007. 2007. Available from: http://www.oireachtas.ie/documents/bills28/acts/2007/a2307.pdf. [Accessed November 18, 2014].

3. Health Technology Assessment (HTA) of Surveillance of Women Aged Less Than 50 Years at Elevated Risk of Breast Cancer;Health Information and Quality Authority, Dublin, Ireland,2013

4. Health Technology Assessment (HTA) of a Population-Based Colorectal Cancer Screening Programme in Ireland;Health Information and Quality Authority, Dublin, Ireland,2009

5. The decision rules of cost-effectiveness analysis;Karlsson;Pharmacoeconomics,1996

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneluxa: What are the Prospects for Collective Bargaining on Pharmaceutical Prices Given Diverse Health Technology Assessment Processes?;PharmacoEconomics;2019-03-08

2. HIQA’s Perspective on the Challenges Posed by Evaluations of Screening Programs: A Reply;Value in Health;2019-01

3. Surveying the Cost-Effectiveness of the 20 Procedures with the Largest Public Health Services Waiting Lists in Ireland: Implications for Ireland’s Cost-Effectiveness Threshold;Value in Health;2018-08

4. Disinvestment in cancer care: a survey investigating European countries’ opinions and views;European Journal of Public Health;2018-03-12

5. The HIQA’s Health Technology Assessment of Breast Screening: Highlighting Some of the Challenges Posed by Evaluations of Screening Programs;Value in Health;2017-07